(Q68737453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

1 reference

C B Powell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

D G Mutch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

M S Kao

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

J L Collins

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 March 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

424-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2317947%20AND%20SRC:MED&resulttype=core&format=json

Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis

27 September 2019

cites work

1 reference

12 December 2020

T-cell inhibition of humoral responsiveness. I. Experimental evidence for restriction by the K- and/or D-end of the H-2 gene complex

1 reference

12 December 2020

Tumorigenicity and lysis by natural killers

1 reference

12 December 2020

Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice

1 reference

12 December 2020

In vivo surveillance of tumorigenic cells transformed in vitro

1 reference

12 December 2020

Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets

1 reference

12 December 2020

An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis

1 reference

12 December 2020

Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential.

1 reference

12 December 2020

In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity

1 reference

12 December 2020

Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man

1 reference

12 December 2020

Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms

1 reference

12 December 2020

Humans express natural cytotoxic (NC) cell activity that is similar to murine NC cell activity.

1 reference

12 December 2020

Effect of mycoplasmas on natural cytotoxic activity and release of tumor necrosis factor alpha by spleen cells

1 reference

12 December 2020

The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells.

1 reference

12 December 2020

In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin

1 reference

12 December 2020

Cyclophosphamide: Use in Practice

1 reference

12 December 2020

Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study

1 reference

12 December 2020

Interaction of aquated cis-[NH3)2Ptii]with nucleic acid constituents. 1. Ribonucleosides

1 reference

12 December 2020

In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain

1 reference

12 December 2020

Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy

1 reference

12 December 2020

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

1 reference

12 December 2020